Fujisaki Fumiko, Toyofuku Keiko, Egami Mayu, Ishida Shiori, Nakamoto Naho, Kashige Nobuhiro, Miake Fumio, Sumoto Kunihiro
Faculty of Pharmaceutical Science, Fukuoka University.
Chem Pharm Bull (Tokyo). 2013;61(10):1090-3. doi: 10.1248/cpb.c13-00461.
In connection with our studies on antibacterial compounds in the class of 5-dialkylaminomethylhydantoins against Gram-negative (Escherichia coli) and Gram-positive (Staphylococcus aureus) strains, some molecular modifications were attempted. The antibacterial activities of all of the synthesized hydantoin derivatives were evaluated. Among the hydantoin derivatives designed in this study, C₂-symmetrical twin-drug type compound (7) showed the highest level of antibacterial activity against S. aureus strain.
在我们对5-二烷基氨基甲基乙内酰脲类抗菌化合物针对革兰氏阴性菌(大肠杆菌)和革兰氏阳性菌(金黄色葡萄球菌)菌株的研究中,尝试了一些分子修饰。对所有合成的乙内酰脲衍生物的抗菌活性进行了评估。在本研究设计的乙内酰脲衍生物中,C₂对称双药型化合物(7)对金黄色葡萄球菌菌株显示出最高水平的抗菌活性。